Australian Life Scientist

Australian Life Scientist Australian Life Scientist

HERPES ZOSTER NOVEL TREATMENT HOPE FROM TASMANIAN ABALONE GETS $1.2 MILLION BOOST

HERPES ZOSTER NOVEL TREATMENT HOPE FROM TASMANIAN ABALONE GETS $1.2 MILLION BOOST HERPES ZOSTER NOVEL TREATMENT HOPE FROM TASMANIAN ABALONE GETS $1.2 MILLION BOOST

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth

Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning at the 46th DIA Annual Meeting June 13-17 in Washington, DC

Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning at the 46th DIA Annual Meeting June 13-17 in Washington, DC Novotech CEO to speak on Clinical Projects - Faster and Smarter it's All in the Planning at the 46th DIA Annual Meeting June 13-17 in Washington, DC

Company News / More »

HERPES ZOSTER NOVEL TREATMENT HOPE FROM TASMANIAN ABALONE GETS $1.2 MILLION BOOST

Sydney, Australia, 23 May 2011 – Leading Australian contract clinical research... 


Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

NOVOTECH  INITIATES PHASE IB CANCER TRIALS IN AUSTRALIA AND NEW ZEALAND FOR CLIENT,... 


Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued... 


Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning at the 46th DIA Annual Meeting June 13-17 in Washington, DC

Washington, DC, June 13, 2010 – Leading Australian contract clinical research company... 


Novotech embarks on a new strategic partnership with Citeline, designed to accelerate patient recruitment and complete clinical studies more quickly.

Novotech embarks on a new strategic partnership with Citeline, designed to accelerate... 


Novotech announces four country Asia expansion at AusBiotech 2009

NOVOTECH ANNOUNCES FOUR COUNTRY ASIA EXPANSION AT AUSBIOTECH 2009 New operations... 


New Study of Investigational Alzheimer’s Disease Treatment Enrolling Patients in Australia

New Study of Investigational Alzheimer’s Disease Treatment Enrolling Patients... 


Novotech wins coveted Australian CRO Award from Frost & Sullivan

San Diego, CA– June 19, 2008 — Novotech, the largest Australian owned contract research... 


View More Company News

Media Reports / More »

TheraVida Initiates Phase 2 Trial of THVD-201 for Overactive Bladder and Urinary Incontinence: selects Novotech

Multi-national Study to be Conducted by Novotech in Australia, New Zealand, and South... 


Novotech in new research collaboration: Biotechnology News

LEADING Australian contract clinical research company Novotech, Marine Biotechnology... 


Australian Life Scientist

Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed California-based... 


CIO

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support... 


iTnews

Novotech runs clinical trials on Oracle  A group of three Phase I trials... 


Outsourcing Pharma

Podcast: Asia Pacific trial sector poised for continued growth, says Novotech ... 


Trials In Focus

Inside Stories – Wide brief for cancer candidate A group of three Phase... 


Trials In Focus

Inside Stories – Asian trial growth creates hurdles Despite rapid growth... 


CenterWatch

Novotech Becomes Medidata Solutions’ Partner Medidata Solutions, a global... 


Medidata Solutions Welcomes First Australian CRO to ASPire to Win Channel Partner Program

Medidata Solutions Welcomes First Australian CRO to ASPire to Win Channel Partner... 


View More Media Reports